Subscribe free

Newsletter

General Surgery

Best Papers in General Surgery

The five that matter, every day.

FreeNo spamOne-click unsubscribe
J Gastrointest Oncol26 Sep 2025

Hepatectomy Enhances Survival in Colorectal Cancer with Multiple Liver Metastases

Patients with unresectable colorectal cancer and 10+ liver metastases experience notable survival benefits from hepatic resection combined with radiofrequency ablation (RFA) and systemic therapy. Three-year survival rates soar to 39.2% for surgery approaches, compared to just 18.6% and 8.2% for RFA plus systemic therapy and…

HPB & Spleen26 Sep 2025

Percutaneous Catheter Drainage Outperforms Aspiration for Liver Abscesses

Percutaneous catheter drainage (PCD) significantly outperformed percutaneous aspiration (PA) in treating liver abscesses. PCD demonstrated higher treatment success rates and led to quicker clinical improvements, reducing recovery time by nearly two days. Additionally, PCD lowered the six-month recurrence rate by 56%. Both methods displayed comparable…

Intestine and Lower Gastrointestinal Tract25 Sep 2025

Methylene Blue Reduces Postoperative Pain After Hemorrhoid Surgery

Methylene blue effectively alleviates postoperative pain and decreases analgesic use in hemorrhoid surgery patients. A meta-analysis of six studies with 598 participants revealed significant pain reduction within 12 hours post-surgery, along with lower analgesic requirements. Importantly, methylene blue demonstrated a safety profile without increasing complications.…

J Surg Oncol25 Sep 2025

Significant Postoperative Complications Erode Survival in Remnant Gastric Cancer Patients

Severe complications after curative surgery for remnant gastric cancer affect long-term outcomes significantly. In a study of 126 patients, those with complications classified as Clavien-Dindo grade ≥ 3a exhibited markedly lower five-year overall survival (32% vs. 65.6%) and recurrence-free survival (33.6% vs. 64.3%). Key risk…

J Gastrointest Oncol25 Sep 2025

High Venous Thromboembolism Risk Identified in Pancreatic Cancer Patients

Venous thromboembolism (VTE) affects 15.6% of pancreatic cancer patients, significantly higher than other malignancies. Key risk factors include tumor location in the body or tail, poorly differentiated tumors, stage IV disease, metastasis, and elevated D-dimer levels post-surgery. The study’s findings emphasize the need for early…

J Gastrointest Oncol25 Sep 2025

Indocyanine Green Outshines Endoscopic Ultrasound in Colorectal Cancer Node Detection

Indocyanine green (ICG) fluorescence imaging significantly surpasses endoscopic ultrasound (EUS) in diagnosing sentinel and lymph node metastasis in colorectal cancer patients. With sensitivities of 94.44% for sentinel nodes and 80.00% for lymph nodes, ICG proved far more accurate than EUS, which lagged at 40.74% and…

J Spec Oper Med25 Sep 2025

Operator Gestalt Outperforms Other Techniques in Blood Bag Filling Accuracy

In prehospital settings, novices using operator gestalt achieved a 69% success rate in correctly filling donor blood bags, significantly surpassing the beaded cable tie (37%) and paracord (52%). For experts, the paracord reached an 80% success rate; however, operator gestalt (70%) was not statistically different.…

J Am Coll Surg24 Sep 2025

Women Outperform Men in Achieving Ideal Outcomes After Pancreatic Surgery

Female patients demonstrated significantly better surgical outcomes following pancreatectomy compared to males, with 62.3% of women achieving ideal outcomes versus 54.1% of men. Women faced fewer complications, lower reoperation rates, and reduced 30-day mortality. The likelihood of achieving optimal results was notably higher for women…

Dis Colon Rectum24 Sep 2025

Achieving YpN0 Status Significantly Enhances Survival in Rectal Cancer

Patients with locally advanced rectal cancer who achieve YpN0 status after neoadjuvant therapy show promising survival rates. In a cohort from the FOWARC trial, five-year overall survival reached 88% for natural N0 and 89% for downstaged N0, far surpassing the 73% survival in YpN+ patients…